In the June Matters in Managed Care webinar, experts from Blue Cross and Blue Shield of North Carolina, Duke-Margolis Center for Health Policy, UNC Center for the Business of Health, and WakeMed discussed how they are working together to address some of the state’s unique primary care needs.
The COVID-19 pandemic magnified the crucial role of primary care in advancing population health. Payers and providers are collaborating in novel ways to expand access to quality, affordable primary care.
In the latest Matters in Managed Care webinar from The American Journal of Managed Care® (AJMC)®, experts from Blue Cross and Blue Shield of North Carolina, Duke-Margolis Center for Health Policy, UNC Center for the Business of Health, and WakeMed sat down to discuss how payers and primary care providers are managing patient needs during this time of pandemic change, including efforts to expand access to value-based care and connect behavioral/mental health, health equity, and primary care.
Brian Klausner, MD, medical director, Community Population Health at WakeMed Primary Care, moderated the June 2021 discussion with Devdutta Sangvai, MD, MBA, vice president, Population Health Management, Duke University Health System; Leslie McKinney, MD, FACEP, senior medical director, Blue Cross NC Advanced Primary Care and Value-Based Provider Engagement; and Rivers Woodward, MD, MBA, family physician, and Blue Ridge Community Health Services.
In part 3, the panel reviews population health opportunities and challenges.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More